#}



Celldex Therapeutics, Inc.

Rachunek Zysków i Strat


Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna



index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Rok finansowy 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 1 1 3 7 5 7 3 5 5 7 15 47 9 11 4 4 5 7 13 10 4 7 5 2 7 7
Przychód Δ r/r 0.0% -48.6% 338.4% 100.4% -30.9% 48.0% -55.0% 59.7% 3.5% 46.1% 103.6% 208.3% -80.2% 20.9% -63.3% -12.8% 52.8% 23.8% 87.8% -25.2% -62.5% 107.6% -37.3% -49.3% 192.0% 2.0%
Marża brutto 148.0% 190.3% 98.9% 99.4% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 44.7% 74.2% 1.6% 3.8% 43.2% 100.0% 100.0% 100.0% 100.0% 100.0% -1094.3% -473.4% 34.0% 40.6% 56.3% 100.0%
EBIT (mln) -12 -15 -25 -14 -12 -14 -19 -22 -23 -49 -37 -6 -43 -58 -81 -122 -130 -133 -122 -156 -55 -63 -71 -115 -142 -195
EBIT Δ r/r 0.0% 29.3% 59.1% -41.2% -18.7% 15.8% 38.9% 18.6% 2.2% 113.3% -24.4% -82.5% 572.3% 33.8% 40.2% 50.3% 5.8% 2.6% -8.6% 28.7% -64.8% 15.1% 12.5% 61.7% 23.3% 37.3%
EBIT (%) -805.1% -2023.2% -734.1% -215.2% -253.3% -198.0% -610.8% -453.6% -447.9% -654.0% -242.8% -13.8% -468.4% -518.5% -1981.1% -3414.1% -2363.9% -1958.7% -953.7% -1640.1% -1540.2% -854.1% -1531.8% -4889.0% -2063.7% -2778.9%
Koszty finansowe (mln) 0 0 0 0 0 0 0 -4 -2 0 0 1 2 2 1 0 0 0 16 151 0 0 0 -3 0 0
EBITDA (mln) -11 -8 -24 -13 -10 -12 -18 -22 -21 -18 -33 -3 -42 -57 -78 -121 -131 -136 -96 -1 -58 -38 -68 -102 -139 -192
EBITDA(%) -713.9% -995.3% -720.7% -200.0% -225.5% -178.5% -566.8% -454.0% -416.7% -240.9% -219.5% -7.1% -453.1% -508.7% -1909.4% -3385.9% -2388.2% -2008.6% -753.6% -6.7% -1628.1% -514.9% -1452.5% -4321.9% -2020.0% -2733.6%
Podatek (mln) -1 13 -4 -1 1 -1 -2 0 -0 27 -1 -5 -0 -1 -1 -4 -2 -9 -24 -1 -1 -1 -0 10 0 0
Zysk Netto (mln) -11 -22 -23 -14 -13 -13 -18 -20 -22 -48 -37 -3 -45 -59 -82 -118 -127 -129 -93 -151 -50 -60 -71 -123 -141 -158
Zysk netto Δ r/r 0.0% 94.3% 3.5% -39.2% -8.4% 4.2% 37.1% 12.6% 6.2% 119.5% -23.1% -93.1% 1668.6% 32.0% 37.9% 44.8% 7.7% 1.0% -27.6% 62.5% -66.7% 18.7% 18.0% 74.1% 15.2% 11.6%
Zysk netto (%) -762.3% -2879.3% -680.0% -206.3% -273.5% -192.5% -586.0% -413.2% -424.0% -637.1% -240.6% -5.4% -483.5% -527.8% -1983.7% -3292.8% -2321.1% -1894.0% -730.1% -1585.1% -1409.8% -805.9% -1516.0% -5209.3% -2054.8% -2248.8%
EPS -46.18 -75.43 -70.63 -41.17 -36.48 -32.57 -43.93 -49.41 -468.75 -50.12 -27.64 -1.19 -17.01 -15.37 -15.33 -19.81 -19.66 -18.99 -10.86 -14.48 -3.47 -2.02 -1.64 -2.62 -2.92 -2.45
EPS (rozwodnione) -46.18 -75.43 -70.63 -41.17 -36.48 -32.57 -43.93 -49.41 -468.75 -50.12 -27.64 -1.19 -17.01 -15.37 -15.33 -19.81 -19.66 -18.99 -10.86 -14.48 -3.47 -2.02 -1.64 -2.62 -2.92 -2.45
Ilośc akcji (mln) 0 0 0 0 0 0 0 0 0 1 1 2 3 4 5 6 6 7 9 10 15 30 43 47 48 64
Ważona ilośc akcji (mln) 0 0 0 0 0 0 0 0 0 1 1 2 3 4 5 6 6 7 9 10 15 30 43 47 48 64
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD